Clinical features of acquired resistance to anti–PD-1 therapy in advanced melanoma

Anti–PD-1 therapy has improved clinical outcomes in advanced melanoma, but most patients experience intrinsic resistance. Responding patients can develop acquired resistance to anti–PD-1. We retrospectively reviewed 488 patients treated with anti–PD-1 from three academic centers and identified 36 pa...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Immunol Res
Main Authors: Wang, Daniel Y., Eroglu, Zeynep, Ozgun, Alpaslan, Leger, Paul D., Zhao, Shilin, Ye, Fei, Luke, Jason J., Joseph, Richard W., Haq, Rizwan, Ott, Patrick A., Hodi, F. Stephen, Sosman, Jeffrey A., Johnson, Douglas B., Buchbinder, Elizabeth I.
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5502536/
https://ncbi.nlm.nih.gov/pubmed/28396509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-16-0287
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items